Asst. Prof. GURBET ÖZGE MERT Asst. Prof. GURBET ÖZGE MERT Personal Information Personal Information

(1)

Asst. Prof. GURBET ÖZGE MERT Asst. Prof. GURBET ÖZGE MERT Personal Information

Personal Information

Email:

Email: [email protected] W eb:

W eb: https://avesis.ogu.edu.tr/3255 Internatio nal Researcher ID s Internatio nal Researcher ID s ScholarID: 3

ORCID: 0000-0001-8350-9758

Publons / Web Of Science ResearcherID: AAH-7736-2019 Yoksis Researcher ID: 200197

Education Information Education Information

Expertise In Medicine, Eskisehir Osmangazi University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey 2009 - 2014 Undergraduate, Ege University, Faculty Of Medicine, Tıp Pr., Turkey 2003 - 2009

Research Areas Research Areas

Health Sciences

Academic Titles / Tasks Academic Titles / Tasks

Assistant Professor, Eskisehir Osmangazi University, Tıp Fakültesi, Dahili Tıp Bil. Bölüm, 2020 - Continues Research Assistant, Eskisehir Osmangazi University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, 2009 - 2014

Published journal articles indexed by SCI, SSCI, and AHCI Published journal articles indexed by SCI, SSCI, and AHCI

I. Co mpariso n o f the pro gno stic value o f neutro phil to lympho cyte ratio s at different time po ints inCo mpariso n o f the pro gno stic value o f neutro phil to lympho cyte ratio s at different time po ints in patients with ST segment elevatio n myo cardial infarctio n by five-year fo llo w-up

patients with ST segment elevatio n myo cardial infarctio n by five-year fo llo w-up Mert G. O. , DURAL M., MERT K. U. , BİLGİN M., GÖRENEK B.

Kuwait Medical Journal, vol.54, no.2, pp.163-171, 2022 (Peer-Reviewed Journal) II. D o es it wo rk fo r atrial high-rate episo des?D o es it wo rk fo r atrial high-rate episo des?

MERT G. Ö. , MERT K. U. , GÖRENEK B.

PACE - Pacing and Clinical Electrophysiology, 2022 (Peer-Reviewed Journal)

III. The value o f perfo rming tho ro ugh echo cardio graphy in patients with co ro nary heart disease andThe value o f perfo rming tho ro ugh echo cardio graphy in patients with co ro nary heart disease and atrial fibrillatio n.

atrial fibrillatio n.

Mert G. Ö. , Babayigit E., Görenek B.

American heart journal, vol.241, pp.121, 2021 (Peer-Reviewed Journal)

IV. Pro gno stic value o f D -dimer/fibrino gen ratio o n in-ho spital o utco mes o f patients with heart failurePro gno stic value o f D -dimer/fibrino gen ratio o n in-ho spital o utco mes o f patients with heart failure and COVID -19.

and COVID -19.

Murat S., Murat B., Dural M., Mert G. Ö. , Cavusoglu Y.

Biomarkers in medicine, vol.15, no.16, pp.1519-1528, 2021 (Peer-Reviewed Journal)

V. Management o f L D L -cho lestero l levels in patients with D iabetes Mellitus in Cardio lo gy Practice:Management o f L D L -cho lestero l levels in patients with D iabetes Mellitus in Cardio lo gy Practice:

Real-life evidence o f Under-treatment fro m the EPHESUS registry.

(2)

Mert K. U. , Başaran Ö., Mert G. Ö. , Doğan V., Rencüzoğulları İ., Özlek B., Cinier G., Şenol U., Çelik O., Özlek E., et al.

European journal of clinical investigation, vol.51, no.7, 2021 (Peer-Reviewed Journal) VI. Evaluatio n o f ventricular arrhythmias witho ut co nsidering ischemia.Evaluatio n o f ventricular arrhythmias witho ut co nsidering ischemia.

Mert G. Ö. , Mert K. U. , Görenek B.

Journal of cardiovascular electrophysiology, vol.32, no.5, pp.1518, 2021 (Peer-Reviewed Journal) VII. The asso ciatio n o f exaggerated hypertensive respo nse to exercise and beta-blo ckers use inThe asso ciatio n o f exaggerated hypertensive respo nse to exercise and beta-blo ckers use in

hypertensives.

Mert K. U. , ŞENER E., Yilmaz A. S. , Mert G. Ö. , Yetmis F., Dural M., Babayigit E., Murat S., ÇAVUŞOĞLU Y., ULUS T., et al.

Clinical and experimental hypertension (New York, N.Y. : 1993), vol.42, no.8, pp.707-713, 2020 (Peer-Reviewed Journal)

VIII. Research update fo r articles published in EJCI in 2017Research update fo r articles published in EJCI in 2017

Arellano-Orden E., Bacopoulou F., Baicus C., Bonfrate L., Broadbent J., Buechler C., Carbone F., Charmandari E., Davis G. R. , Dullaart R. P. F. , et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, vol.49, no.10, 2019 (Peer-Reviewed Journal)

IX. Co ntempo rary Presentatio n and Management o f Valvular Heart D isease The EURObservatio nalCo ntempo rary Presentatio n and Management o f Valvular Heart D isease The EURObservatio nal Research Pro gramme Valvular Heart D isease II Survey

Research Pro gramme Valvular Heart D isease II Survey

Iung B., Delgado V., Rosenhek R., Price S., Prendergast B., Wendler O., De Bonis M., Tribouilloy C., Evangelista A., Bogachev-Prokophiev A., et al.

CIRCULATION, vol.140, no.14, pp.1156-1169, 2019 (Peer-Reviewed Journal)

X. Risk stratificatio n and timing fo r invasive appro ach in patients with no n-STEMIRisk stratificatio n and timing fo r invasive appro ach in patients with no n-STEMI Mert K. U. , Mert G. Ö.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.37, no.9, pp.1792-1793, 2019 (Peer-Reviewed Journal) XI. The reaso ns o f po o r lipid target attainment fo r seco ndary preventio n in real life practice: ResultsThe reaso ns o f po o r lipid target attainment fo r seco ndary preventio n in real life practice: Results

fro m EPHESUS fro m EPHESUS

Mert G. Ö. , Basaran O., Mert K. U. , DOĞAN V., Ozlek B., Celik O., Ozlek E., Cil C., Ozdemir I. H. , RENCÜZOĞULLARI İ., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, vol.73, no.9, 2019 (Peer-Reviewed Journal) XII. Gerbo de defect: A rare co mplicatio n o f infective endo carditisGerbo de defect: A rare co mplicatio n o f infective endo carditis

Mert G. Ö. , Dural M., Gorenek B., Mert K. U.

JOURNAL OF POSTGRADUATE MEDICINE, vol.65, no.3, pp.184-185, 2019 (Peer-Reviewed Journal)

XIII. Geo graphical Variatio ns in Patients with Heart F ailure and Preserved Ejectio n F ractio n: A Sub-Gro upGeo graphical Variatio ns in Patients with Heart F ailure and Preserved Ejectio n F ractio n: A Sub-Gro up Analysis o f the APOL L ON Registry

Analysis o f the APOL L ON Registry

Ozlek B., Ozlek E., Agus H. Z. , Tekinalp M., Kahraman S., Celik O., Cil C., Basaran O., DOĞAN V., Kaya B. C. , et al.

BALKAN MEDICAL JOURNAL, vol.36, no.4, pp.235-244, 2019 (Peer-Reviewed Journal)

XIV. Gender disparities in heart failure with mid-range and preserved ejectio n fractio n: Results fro mGender disparities in heart failure with mid-range and preserved ejectio n fractio n: Results fro m APOL L ON study

APOL L ON study

Ozlek B., Ozlek E., Kahraman S., Tekinalp M., Agus H. Z. , Celik O., Cil C., DOĞAN V., Basaran O., Kaya B. C. , et al.

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.21, no.5, pp.242-252, 2019 (Peer-Reviewed Journal)

XV. Clinical features o f heart failure with mid-range and preserved ejectio n fractio n in o cto genarians:Clinical features o f heart failure with mid-range and preserved ejectio n fractio n in o cto genarians:

Results o f a multicentre, o bservatio nal study Results o f a multicentre, o bservatio nal study

Ozlek B., Ozlek E., Tekinalp M., Kahraman S., Agus H. Z. , Celik O., Cil C., Kaya B. C. , RENCÜZOĞULLARI İ., Mert K. U. , et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, vol.73, no.4, 2019 (Peer-Reviewed Journal)

XVI. Patients with HF pEF and HF mrEF have different clinical characteristics in Turkey: A multicenterPatients with HF pEF and HF mrEF have different clinical characteristics in Turkey: A multicenter o bservatio nal study

o bservatio nal study

Ozlek B., Ozlek E., Agus H. Z. , Tekinalp M., Kahraman S., Cil C., Celik O., Basaran O., DOĞAN V., Kaya B. C. , et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE, vol.61, pp.88-95, 2019 (Peer-Reviewed Journal) XVII. The diagno stic challenge: Tako tsubo cardio myo pathy vs. acute myo carditisThe diagno stic challenge: Tako tsubo cardio myo pathy vs. acute myo carditis

Mert G. Ö. , Radi F., Mert K. U.

HEART & LUNG, vol.47, no.6, pp.646, 2018 (Peer-Reviewed Journal)

(3)

XVIII. F acts and details: Ivabradine in acute deco mpensated heart failureF acts and details: Ivabradine in acute deco mpensated heart failure Mert K. U. , Babayigit E., Mert G. Ö. , ÇAVUŞOĞLU Y.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.271, pp.210, 2018 (Peer-Reviewed Journal) XIX. Beneficial effects o f ivabradine in atrial o r ventricular arrhythmiasBeneficial effects o f ivabradine in atrial o r ventricular arrhythmias

Mert K. U. , ŞENER E., Mert G. Ö.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, vol.41, no.11, pp.1575, 2018 (Peer-Reviewed Journal) XX. Success predicto r o f cryo ballo o n ablatio n in atrial fibrillatio n: L eft atrial vo lume vs areaSuccess predicto r o f cryo ballo o n ablatio n in atrial fibrillatio n: L eft atrial vo lume vs area

Mert G. Ö. , Mert K. U. , GÖRENEK B.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.270, pp.188, 2018 (Peer-Reviewed Journal)

XXI. Co mpariso n o f acute management o f atrial fibrillatio n in heart failure with unequal sized gro upsCo mpariso n o f acute management o f atrial fibrillatio n in heart failure with unequal sized gro ups Mert G. Ö. , Dural M., Mert K. U.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.36, no.9, pp.1693, 2018 (Peer-Reviewed Journal) XXII. No ninvasive predicto rs o f cardiac arrhythmias in bo dybuildersNo ninvasive predicto rs o f cardiac arrhythmias in bo dybuilders

Mert K. U. , Ilguy S., Mert G. Ö. , Dural M., Iskenderov K.

REVISTA PORTUGUESA DE CARDIOLOGIA, vol.37, no.8, pp.693-701, 2018 (Peer-Reviewed Journal) XXIII. Pro gno stic relevance o f left ventricle thro mbus vs. ST elevatio n in Tako tsubo syndro mePro gno stic relevance o f left ventricle thro mbus vs. ST elevatio n in Tako tsubo syndro me

Mert G. Ö. , Mert K. U. , Biteker M.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.258, pp.28, 2018 (Peer-Reviewed Journal)

XXIV. Effects o f heart rate reductio n with ivabradine o n the internatio nal ndex o f erectile functio n (IIEF -Effects o f heart rate reductio n with ivabradine o n the internatio nal ndex o f erectile functio n (IIEF - 5) in patients with heart failure

5) in patients with heart failure

Mert K. U. , Dural M., Mert G. Ö. , Iskenderov K., Ozen A.

AGING MALE, vol.21, no.2, pp.93-98, 2018 (Peer-Reviewed Journal)

XXV. Is electrical cardio versio n do able in atrial fibrillatio n witho ut transeso phageal echo cardio graphy?Is electrical cardio versio n do able in atrial fibrillatio n witho ut transeso phageal echo cardio graphy?

Mert K. U. , Dural M., Mert G. Ö.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.247, pp.20, 2017 (Peer-Reviewed Journal) XXVI. Successful management o f iatro genic retro grade dissectio n into the ao rtic ro o tSuccessful management o f iatro genic retro grade dissectio n into the ao rtic ro o t

Mert K. U. , Mert G. Ö. , Dizman R.

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.18, no.3, pp.235-237, 2017 (Peer-Reviewed Journal) XXVII. Questio ning reliability o f o bservatio nal studyQuestio ning reliability o f o bservatio nal study

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, vol.40, no.9, pp.1046, 2017 (Peer-Reviewed Journal) XXVIII. Effects o f creatine supplementatio n o n cardiac auto no mic functio ns in bo dybuildersEffects o f creatine supplementatio n o n cardiac auto no mic functio ns in bo dybuilders

Mert K. U. , Ilguy S., Dural M., Mert G. Ö. , ÖZAKIN E.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, vol.40, no.6, pp.721-727, 2017 (Peer-Reviewed Journal) XXIX. Real-wo rld stro ke preventio n strategies in no nvalvular atrial fibrillatio n in patients with renalReal-wo rld stro ke preventio n strategies in no nvalvular atrial fibrillatio n in patients with renal

impairment impairment

Mert K. U. , Mert G. Ö. , Basaran O., BETON O., DOĞAN V., Tekinalp M., Aykan A. C. , Kalaycioglu E., Bolat I., Tasar O., et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, vol.47, no.6, pp.428-438, 2017 (Peer-Reviewed Journal) XXX. PRescriptiOn PattERns o f Oral Antico agulants in No nvalvular Atrial F ibrillatio n (PROPER study)PRescriptiOn PattERns o f Oral Antico agulants in No nvalvular Atrial F ibrillatio n (PROPER study)

Basaran O., Basaran N. F. , Cekic E. G. , Altun I., Dogan V., Mert G. Ö. , Mert K. U. , Akin F., Soylu M. O. , Sancar K. M. , et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.23, no.4, pp.384-391, 2017 (Peer-Reviewed Journal) XXXI. Electro magnetic interference o f mo bile pho nes: insight into heart rate variabilityElectro magnetic interference o f mo bile pho nes: insight into heart rate variability

Mert K. U. , Dural M., Mert G. Ö. , Iskenderov K.

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.17, no.3, pp.248, 2017 (Peer-Reviewed Journal)

XXXII. Cutaneo us micro vascular reactivity and ao rtic elasticity in co ro nary artery disease: Co mpariso n o fCutaneo us micro vascular reactivity and ao rtic elasticity in co ro nary artery disease: Co mpariso n o f the laser D o ppler flo wmetry and echo cardio graphy

the laser D o ppler flo wmetry and echo cardio graphy

Cekic E. G. , Basaran O., Basaran N. F. , Elmas O., Dogan V., Mert G. Ö. , Mert K. U. , Altun I., Akin F., Biteker M.

MICROVASCULAR RESEARCH, vol.109, pp.19-25, 2017 (Peer-Reviewed Journal)

XXXIII. Effects o f ivabradine and beta-blo cker therapy o n do butamine-induced ventricular arrhythmiasEffects o f ivabradine and beta-blo cker therapy o n do butamine-induced ventricular arrhythmias

(4)

Mert K. U. , Mert G. Ö. , Morrad B., Tahmazov S., MUTLU F., ÇAVUŞOĞLU Y.

KARDIOLOGIA POLSKA, vol.75, no.8, pp.786-793, 2017 (Peer-Reviewed Journal)

XXXIV. Real-life use o f digo xin in patients with no n-valvular atrial fibrillatio n: data fro m the RAMSES studyReal-life use o f digo xin in patients with no n-valvular atrial fibrillatio n: data fro m the RAMSES study Biteker M., Basaran O., Dogan V., Beton O., Tekinalp M., Aykan A. C. , Kalaycioglu E., Bolat I., TaSar O., Safak O., et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, vol.41, no.6, pp.711-717, 2016 (Peer-Reviewed Journal) XXXV. Co ro nary artery disease in o utpatients with no nvalvular atrial fibrillatio n: results fro m theCo ro nary artery disease in o utpatients with no nvalvular atrial fibrillatio n: results fro m the

multicenter RAMSES study multicenter RAMSES study

Dogan V., Basaran O., Beton O., Tekinalp M., Bolat I., Kalaycioglu E., Aykan A. C. , Tasar O., Safak O., Kalcik M., et al.

CORONARY ARTERY DISEASE, vol.27, no.6, pp.497-503, 2016 (Peer-Reviewed Journal)

XXXVI. Subo ptimal use o f no n-vitamin K antago nist o ral antico agulants: Results fro m the RAMSES studySubo ptimal use o f no n-vitamin K antago nist o ral antico agulants: Results fro m the RAMSES study Basaran O., Dogan V., Beton O., Tekinalp M., Aykan A. C. , Kalaycioglu E., Bolat I., Tasar O., Safak O., Kalcik M., et al.

MEDICINE, vol.95, no.35, 2016 (Peer-Reviewed Journal)

XXXVII. Co mmentary: Peripartum Cardio myo pathy in Intensive Care Unit: an UpdateCo mmentary: Peripartum Cardio myo pathy in Intensive Care Unit: an Update Biteker M., Mert K. U. , Mert G. Ö.

FRONTIERS IN MEDICINE, vol.3, 2016 (Peer-Reviewed Journal) XXXVIII. W hat is yo ur diagno sis? B. F ree-flo ating thro mbusW hat is yo ur diagno sis? B. F ree-flo ating thro mbus

Mert K. U. , Mert G. Ö. , Karabay C. Y. , Kalayci A.

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.16, no.2, pp.141-142, 2016 (Peer-Reviewed Journal)

XXXIX. Management o f pro sthetic valve thro mbo sis: what is the best do sage and administratio n ro ute o fManagement o f pro sthetic valve thro mbo sis: what is the best do sage and administratio n ro ute o f thro mbo lytics

thro mbo lytics

Biteker M., Basaran O., Mert G. Ö. , Dogan V., Mert K. U.

BLOOD COAGULATION & FIBRINOLYSIS, vol.26, no.4, pp.477-478, 2015 (Peer-Reviewed Journal) XL. Ivabradine in cardio genic sho ck: F act o r fictio n?Ivabradine in cardio genic sho ck: F act o r fictio n?

Mert K. U. , Mert G. Ö. , Altun I., Biteker M.

HEART & LUNG, vol.44, no.2, pp.178, 2015 (Peer-Reviewed Journal) XLI. Treatment o f Ko unis syndro meTreatment o f Ko unis syndro me

Dogan V., Mert G. Ö. , Biteker F. S. , Mert K. U. , Biteker M.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.181, pp.133-134, 2015 (Peer-Reviewed Journal) XLII. B-type natriuretic peptide in infective endo carditisB-type natriuretic peptide in infective endo carditis

Biteker F. S. , Mert G. Ö. , Mert K. U. , Biteker M.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol.31, pp.68, 2015 (Peer-Reviewed Journal) XLIII. Tako tsubo cardio myo pathy o r Ko unis syndro me o r bo th?Tako tsubo cardio myo pathy o r Ko unis syndro me o r bo th?

Mert G. Ö. , Biteker F. S. , Mert K. U. , Basaran O., Dogan V., Biteker M.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.179, pp.16, 2015 (Peer-Reviewed Journal) XLIV. Infective endo carditis pro phylaxis in transcatheter ao rtic valve replacementInfective endo carditis pro phylaxis in transcatheter ao rtic valve replacement

Biteker F. S. , Mert K. U. , Mert G. Ö. , Dogan V., Biteker M.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.177, no.3, pp.1066, 2014 (Peer-Reviewed Journal) XLV. D o es ivabradine really limit do butamine-induced tachycardia in stable heart failure patients:D o es ivabradine really limit do butamine-induced tachycardia in stable heart failure patients:

Parallax in significance Parallax in significance

Mert K. U. , Mert G. Ö. , Basaran O., Biteker M.

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.177, no.2, pp.726, 2014 (Peer-Reviewed Journal) XLVI. Ko unis syndro me and antibio ticsKo unis syndro me and antibio tics

Biteker F. S. , Dogan V., Mert K. U. , Mert G. Ö. , Biteker M.

ANNALS OF SAUDI MEDICINE, vol.34, no.6, pp.556, 2014 (Peer-Reviewed Journal)

Articles Published in Other Journals Articles Published in Other Journals

I. Changing in Gender D ifferences in Heart Rate Variability in Healthy Human Acco rding to Age: Cro ss-Changing in Gender D ifferences in Heart Rate Variability in Healthy Human Acco rding to Age: Cro ss- Sectio nal Study

Sectio nal Study

MERT G. Ö. , BABAYİĞİT E., MURAT S., DURAL M., MERT K. U.

(5)

Turkiye Klinikleri Cardiovascular Sciences, vol.33, 2021 (Peer-Reviewed Journal)

II. Co mpariso n o f clinical characteristics o f patients with heart failure and preserved ejectio n fractio nCo mpariso n o f clinical characteristics o f patients with heart failure and preserved ejectio n fractio n with atrial fibrillatio n versus sinus rhythm: Insights fro m the APOL L ON registry.

with atrial fibrillatio n versus sinus rhythm: Insights fro m the APOL L ON registry.

Ozlek B., Ozlek E., Tekinalp M., Kahraman S., Agus H. Z. , Basaran O., Kaya B. C. , RENCÜZOĞULLARI İ., Mert K. U. , Cakir O., et al.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, vol.48, no.3, pp.234-245, 2020 (Peer- Reviewed Journal)

III. Ratio nale, design, and metho do lo gy o f the Evaluatio n o f Perceptio ns, Kno wledge, and Co mplianceRatio nale, design, and metho do lo gy o f the Evaluatio n o f Perceptio ns, Kno wledge, and Co mpliance with the Guidelines in Real L ife Practice: A Survey o n the Under-treatment o f Hypercho lestero lemia with the Guidelines in Real L ife Practice: A Survey o n the Under-treatment o f Hypercho lestero lemia DOĞAN V., Basaran O., Ozlek B., Celik O., Ozlek E., Mert K. U. , RENCÜZOĞULLARI İ., Mert G. Ö. , Dogan M. M. , Biteker M., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, vol.46, no.1, pp.47- 53, 2018 (Peer-Reviewed Journal)

IV. Evaluatio n o f increase in intraventricular gradient and dynamic o bstructio n during exercise stressEvaluatio n o f increase in intraventricular gradient and dynamic o bstructio n during exercise stress test in co mpetitive runners

test in co mpetitive runners

Mert K. U. , Radi F., Sadati A., Mert G. Ö. , Dural M.

V. Ratio nale, design and metho do lo gy o f the RAMSES Study: ReAl-life Multicenter Survey EvaluatingRatio nale, design and metho do lo gy o f the RAMSES Study: ReAl-life Multicenter Survey Evaluating Stro ke Preventio n Strategies

Stro ke Preventio n Strategies

Basaran O., Dogan V., Sancar K. M. , Altun I., Mert K. U. , Mert G. Ö. , Basaran N. F. , Cekic E. G. , Kirma C., Biteker M.

Books & Book Chapters Books & Book Chapters

I. Akut Bacak İskemisi GirişimleriAkut Bacak İskemisi Girişimleri MERT G. Ö.

in: Periferik Vaküler Girişimler, AHMET İLKER TEKKEŞİN, Editor, Çağlayan Kitabevi, pp.14-42, 2021

Refereed Congress / Symposium Publications in Proceedings Refereed Congress / Symposium Publications in Proceedings

I. THE ONSET OF SYMPTOMS IN MYOCARD IAL BRID GING: D ESTRUCTION OR ATHEROSCL EROSIS?THE ONSET OF SYMPTOMS IN MYOCARD IAL BRID GING: D ESTRUCTION OR ATHEROSCL EROSIS?

MERT G. Ö. , OVALI C., AYDIN N., MURAT S., MERT K. U. , DURAL M.

17th International Congress of Update in Cardiology and Cardiovascular Surgery, 5 - 07 November 2021 II. Co nco rdance between quantitative and semi-quantitative analysis o f Tc-99m-pyro pho sphateCo nco rdance between quantitative and semi-quantitative analysis o f Tc-99m-pyro pho sphate scintigraphy fo r the diagno sis o f transthyretin cardiac amylo ido sis in patients with HF pEF scintigraphy fo r the diagno sis o f transthyretin cardiac amylo ido sis in patients with HF pEF MURAT S., YALVAÇ H. E. , MERT G. Ö. , AK SİVRİKOZ İ., ÇAVUŞOĞLU Y.

ESC Congress 2021, France, 27 - 30 August 2021, vol.42, pp.854-855

III. Smo king Status was Asso ciated with Blo o d Pressure Increase during Exercise in Patients withSmo king Status was Asso ciated with Blo o d Pressure Increase during Exercise in Patients with Hypertensio n

Hypertensio n

MERT K. U. , MERT G. Ö. , MURAT S.

36. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 3 - 06 December 2020

IV. The relatio nship between beta blo cker types and exaggerated blo o d pressure respo nse to exerciseThe relatio nship between beta blo cker types and exaggerated blo o d pressure respo nse to exercise DURAL M., MERT K. U. , MERT G. Ö. , YILMAZ A. S.

V. Atriyal septal defekt kapama cihazının malpo zisyo nuna bağlı geç dö nem tro mbüs gelişimiAtriyal septal defekt kapama cihazının malpo zisyo nuna bağlı geç dö nem tro mbüs gelişimi MURAT S., BEKTAŞ M., MERT G. Ö. , MERT K. U.

(6)

VI. The relatio nship between beta blo cker types and exaggerated blo o d pressure respo nse to exerc!seThe relatio nship between beta blo cker types and exaggerated blo o d pressure respo nse to exerc!se Dural M., Mert K. U. , MERT G. Ö. , Yılmaz A. S.

VII. L IPID MANAGEMENT AND L D L -C GOAL ATTAINMENT IN PRIMARY PREVENTION: AN ANAL YSIS OFL IPID MANAGEMENT AND L D L -C GOAL ATTAINMENT IN PRIMARY PREVENTION: AN ANAL YSIS OF EPHESUS STUD Y

EPHESUS STUD Y

BAŞARAN Ö., DOĞAN V., MERT G. Ö. , MERT K. U. , BULENT Ö., CELİK O., OZLEK E., CİL C., BEKAR L., RESULZADE M., et al.

88TH EAS CONGRESS 2020, 4 - 07 October 2020, vol.315, pp.167-168 VIII. Sympathetic Predo minance in Patients with Hypertensio nSympathetic Predo minance in Patients with Hypertensio n

DURAL M., MERT K. U. , MERT G. Ö.

16th International Congress of Update in Cardiology and Cardiovascular Surgery, 30 October - 01 November 2020 IX. L IPID L OW ERING THERAPY USE IN SECOND ARY PREVENTION: AN ANAL YSIS OF EPHESUS STUD YL IPID L OW ERING THERAPY USE IN SECOND ARY PREVENTION: AN ANAL YSIS OF EPHESUS STUD Y

Basaran O., Dogan V., Mert G. Ö. , Mert K. U. , Ozlek B., Celik O., Ozlek E., Cil C., Bekar L., Aktas M., et al.

87th Congress of the European-Atherosclerosis-Society (EAS), Maastricht, Netherlands, 26 - 29 May 2019, vol.287 X. Reductio n in sympathetic activity in patients with ao rtic steno sis after transcatheter ao rtic valveReductio n in sympathetic activity in patients with ao rtic steno sis after transcatheter ao rtic valve

implantatio n implantatio n

European-Society-of-Cardiology Congress, Munich, Germany, 25 - 29 August 2018, vol.39, pp.1130

Metrics Metrics

Publication: 63 Citation (WoS): 246 Citation (Scopus): 259 H-Index (WoS): 7 H-Index (Scopus): 7